Molecular Detection of Micrometastatic Breast Cancer in Histopathology-Negative Axillary Lymph Nodes Correlates With Traditional Predictors of Prognosis
- 1 June 2004
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Annals of Surgery
- Vol. 239 (6), 828-840
- https://doi.org/10.1097/01.sla.0000128687.59439.d6
Abstract
We sought to establish the clinical relevance of micrometastatic disease detected by reverse transcription polymerase chain reaction (RT-PCR) in axillary lymph nodes (ALN) of breast cancer patients. The presence of ALN metastases remains one of the most valuable prognostic indicators in women with breast cancer. However, the clinical relevance of molecular detection of micrometastatic breast cancer in sentinel lymph nodes (SLN) and nonsentinel ALN has not been established. Four hundred eighty-nine patients with T1-T3 primary breast cancers were analyzed in a prospective, multi-institutional cohort study. ALN were analyzed by standard histopathology (H&E staining) and by multimarker, real-time RT-PCR analysis (mam, mamB, muc1, CEA, PSE, CK19, and PIP) designed to detect breast cancer micrometastases. A positive marker signal was observed in 126 (87%) of 145 subjects with pathology-positive ALN, and in 112 (33%) of 344 subjects with pathology-negative ALN. In subjects with pathology-negative ALN, a positive marker signal was significantly associated with traditional indicators of prognosis, such as histologic grade (P = 0.0255) and St. Gallen risk category (P = 0.022). Mammaglobin was the most informative marker in the panel. This is the first report to show that overexpression of breast cancer-associated genes in breast cancer subjects with pathology-negative ALN correlates with traditional indicators of disease prognosis. These interim results provide strong evidence that molecular markers could serve as valid surrogates for the detection of occult micrometastases in ALN. Correlation of real-time RT-PCR analyses with disease-free survival in this patient cohort will help to define the clinical relevance of micrometastatic disease in this patient population.Keywords
This publication has 42 references indexed in Scilit:
- Clinical relevance of reverse transcriptase-polymerase chain reaction for the detection of axillary lymph node metastases in breast cancer.Annals of Surgical Oncology, 2003
- Occult Axillary Lymph Node Metastases in Breast Cancer Do MatterThe American Journal of Surgical Pathology, 2002
- mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patientsThe Journal of Pathology, 2001
- Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panelInternational Journal of Cancer, 2001
- Selection of mRNA markers for detection of lymph node micrometastases in breast cancer patients.Oncology Reports, 2000
- Unreliability of carcinoembryonic antigen (CEA) reverse transcriptase-polymerase chain reaction (RT-PCR) in detecting contaminating breast cancer cells in peripheral blood stem cells due to induction of CEA by growth factorsBone Marrow Transplantation, 1999
- Use of Reverse-Transcriptase Polymerase Chain Reaction (RT-PCR) for Carcinoembryonic Antigen, Cytokeratin 19, and Maspin in the Detection of Tumor Cells in Leukapheresis Products from Patients with Breast Cancer: Comparison with ImmunocytochemistryJournal of Hematotherapy, 1999
- Prognostic Significance of Vascular Endothelial Growth Factor Protein in Node-Negative Breast CarcinomaJNCI Journal of the National Cancer Institute, 1997
- Assessing Test Accuracy and its Clinical Consequences: A Primer for Receiver Operating Characteristic Curve AnalysisAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1993
- Are Positive Axillary Nodes in Breast Cancer Markers for Incurable Disease?Annals of Surgery, 1993